Optimizing Heart Failure Management

This chapter explores the hierarchy of treatment options for heart failure with reduced ejection fraction, emphasizing the roles of ACE inhibitors, ARBs, and ARNIs. It covers practical considerations such as patient accessibility to medications and the financial implications of treatment choices, including the strategic use of generics. The discussion highlights recent trials that underscore the benefits of early high-intensity medication management following hospital discharge to improve patient outcomes.